Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
MENA Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A16112
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 MENA Vaccine Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 MENA Vaccine Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 MENA Vaccine Market - Breakup by Product Type
6.1 Multivalent Vaccine
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Monovalent Vaccine
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
7 MENA Vaccine Market - Breakup by Treatment Type
7.1 Preventive Vaccine
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Therapeutic Vaccine
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
8 MENA Vaccine Market - Breakup by Technology
8.1 Conjugate Vaccines
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Inactivated and Subunit Vaccines
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Forecast (2024-2032)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Forecast (2024-2032)
8.6 Others
8.6.1 Historical and Current Market Trends (2018-2023)
8.6.2 Market Forecast (2024-2032)
9 MENA Vaccine Market - Breakup by Route of Administration
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Oral Administration
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Others
9.3.1 Historical and Current Market Trends (2018-2023)
9.3.2 Market Forecast (2024-2032)
10 MENA Vaccine Market - Breakup by Patient Type
10.1 Pediatric
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Forecast (2024-2032)
10.2 Adult
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Forecast (2024-2032)
11 MENA Vaccine Market - Breakup by Indication
11.1 Bacterial Diseases
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2018-2023)
11.1.3 Market Segmentation
11.1.3.1 Meningococcal Disease
11.1.3.2 Pneumococcal Disease
11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
11.1.3.4 Tuberculosis
11.1.3.5 Haemophilus Influenzae (Hib)
11.1.3.6 Typhoid
11.1.3.7 Others
11.1.4 Market Forecast (2024-2032)
11.2 Viral Diseases
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2018-2023)
11.2.3 Market Segmentation
11.2.3.1 Hepatitis
11.2.3.2 Influenza
11.2.3.3 Human Papillomavirus (HPV)
11.2.3.4 Measles/Mumps/Rubella (MMR)
11.2.3.5 Rotavirus
11.2.3.6 Herpes Zoster
11.2.3.7 Varicella
11.2.3.8 Japanese Encephalitis
11.2.3.9 Rubella
11.2.3.10 Polio
11.2.3.11 Rabies
11.2.3.12 Dengue
11.2.3.13 Others
11.2.4 Market Forecast (2024-2032)
12 MENA Vaccine Market - Breakup by Distribution Channel
12.1 Hospital Pharmacies
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2018-2023)
12.1.3 Market Forecast (2024-2032)
12.2 Retail Pharmacies
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2018-2023)
12.2.3 Market Forecast (2024-2032)
12.3 Institutional Sale
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2018-2023)
12.3.3 Market Forecast (2024-2032)
12.4 Others
12.4.1 Overview
12.4.2 Historical and Current Market Trends (2018-2023)
12.4.3 Market Forecast (2024-2032)
13 MENA Vaccine Market - Breakup by End User
13.1 Hospitals
13.1.1 Overview
13.1.2 Historical and Current Market Trends (2018-2023)
13.1.3 Market Forecast (2024-2032)
13.2 Clinics
13.2.1 Overview
13.2.2 Historical and Current Market Trends (2018-2023)
13.2.3 Market Forecast (2024-2032)
13.3 Vaccination Centers
13.3.1 Overview
13.3.2 Historical and Current Market Trends (2018-2023)
13.3.3 Market Forecast (2024-2032)
13.4 Academic and Research Institutes
13.4.1 Overview
13.4.2 Historical and Current Market Trends (2018-2023)
13.4.3 Market Forecast (2024-2032)
13.5 Others
13.5.1 Historical and Current Market Trends (2018-2023)
13.5.2 Market Forecast (2024-2032)
14 MENA Vaccine Market – Breakup by Country
14.1 Saudi Arabia
14.1.1 Overview
14.1.2 Historical and Current Market Trends (2018-2023)
14.1.3 Market Breakup by Product Type
14.1.4 Market Breakup by Treatment Type
14.1.5 Market Breakup by Technology
14.1.6 Market Breakup by Route of Administration
14.1.7 Market Breakup by Patient Type
14.1.8 Market Breakup by Indication
14.1.9 Market Breakup by Distribution Channel
14.1.10 Market Breakup by End User
14.1.11 Key Players
14.1.12 Market Forecast (2024-2032)
14.2 Turkey
14.2.1 Overview
14.2.2 Historical and Current Market Trends (2018-2023)
14.2.3 Market Breakup by Product Type
14.2.4 Market Breakup by Treatment Type
14.2.5 Market Breakup by Technology
14.2.6 Market Breakup by Route of Administration
14.2.7 Market Breakup by Patient Type
14.2.8 Market Breakup by Indication
14.2.9 Market Breakup by Distribution Channel
14.2.10 Market Breakup by End User
14.2.11 Key Players
14.2.12 Market Forecast (2024-2032)
14.3 Israel
14.3.1 Overview
14.3.2 Historical and Current Market Trends (2018-2023)
14.3.3 Market Breakup by Product Type
14.3.4 Market Breakup by Treatment Type
14.3.5 Market Breakup by Technology
14.3.6 Market Breakup by Route of Administration
14.3.7 Market Breakup by Patient Type
14.3.8 Market Breakup by Indication
14.3.9 Market Breakup by Distribution Channel
14.3.10 Market Breakup by End User
14.3.11 Key Players
14.3.12 Market Forecast (2024-2032)
14.4 United Arab Emirates
14.4.1 Overview
14.4.2 Historical and Current Market Trends (2018-2023)
14.4.3 Market Breakup by Product Type
14.4.4 Market Breakup by Treatment Type
14.4.5 Market Breakup by Technology
14.4.6 Market Breakup by Route of Administration
14.4.7 Market Breakup by Patient Type
14.4.8 Market Breakup by Indication
14.4.9 Market Breakup by Distribution Channel
14.4.10 Market Breakup by End User
14.4.11 Key Players
14.4.12 Market Forecast (2024-2032)
14.5 Egypt
14.5.1 Overview
14.5.2 Historical and Current Market Trends (2018-2023)
14.5.3 Market Breakup by Product Type
14.5.4 Market Breakup by Treatment Type
14.5.5 Market Breakup by Technology
14.5.6 Market Breakup by Route of Administration
14.5.7 Market Breakup by Patient Type
14.5.8 Market Breakup by Indication
14.5.9 Market Breakup by Distribution Channel
14.5.10 Market Breakup by End User
14.5.11 Key Players
14.5.12 Market Forecast (2024-2032)
14.6 Iran
14.6.1 Overview
14.6.2 Historical and Current Market Trends (2018-2023)
14.6.3 Market Breakup by Product Type
14.6.4 Market Breakup by Treatment Type
14.6.5 Market Breakup by Technology
14.6.6 Market Breakup by Route of Administration
14.6.7 Market Breakup by Patient Type
14.6.8 Market Breakup by Indication
14.6.9 Market Breakup by Distribution Channel
14.6.10 Market Breakup by End User
14.6.11 Key Players
14.6.12 Market Forecast (2024-2032)
14.7 Iraq
14.7.1 Overview
14.7.2 Historical and Current Market Trends (2018-2023)
14.7.3 Market Breakup by Product Type
14.7.4 Market Breakup by Treatment Type
14.7.5 Market Breakup by Technology
14.7.6 Market Breakup by Route of Administration
14.7.7 Market Breakup by Patient Type
14.7.8 Market Breakup by Indication
14.7.9 Market Breakup by Distribution Channel
14.7.10 Market Breakup by End User
14.7.11 Key Players
14.7.12 Market Forecast (2024-2032)
14.8 Qatar
14.8.1 Overview
14.8.2 Historical and Current Market Trends (2018-2023)
14.8.3 Market Breakup by Product Type
14.8.4 Market Breakup by Treatment Type
14.8.5 Market Breakup by Technology
14.8.6 Market Breakup by Route of Administration
14.8.7 Market Breakup by Patient Type
14.8.8 Market Breakup by Indication
14.8.9 Market Breakup by Distribution Channel
14.8.10 Market Breakup by End User
14.8.11 Key Players
14.8.12 Market Forecast (2024-2032)
14.9 Algeria
14.9.1 Overview
14.9.2 Historical and Current Market Trends (2018-2023)
14.9.3 Market Breakup by Product Type
14.9.4 Market Breakup by Treatment Type
14.9.5 Market Breakup by Technology
14.9.6 Market Breakup by Route of Administration
14.9.7 Market Breakup by Patient Type
14.9.8 Market Breakup by Indication
14.9.9 Market Breakup by Distribution Channel
14.9.10 Market Breakup by End User
14.9.11 Key Players
14.9.12 Market Forecast (2024-2032)
14.10 Kuwait
14.10.1 Overview
14.10.2 Historical and Current Market Trends (2018-2023)
14.10.3 Market Breakup by Product Type
14.10.4 Market Breakup by Treatment Type
14.10.5 Market Breakup by Technology
14.10.6 Market Breakup by Route of Administration
14.10.7 Market Breakup by Patient Type
14.10.8 Market Breakup by Indication
14.10.9 Market Breakup by Distribution Channel
14.10.10 Market Breakup by End User
14.10.11 Key Players
14.10.12 Market Forecast (2024-2032)
14.11 Morocco
14.11.1 Overview
14.11.2 Historical and Current Market Trends (2018-2023)
14.11.3 Market Breakup by Product Type
14.11.4 Market Breakup by Treatment Type
14.11.5 Market Breakup by Technology
14.11.6 Market Breakup by Route of Administration
14.11.7 Market Breakup by Patient Type
14.11.8 Market Breakup by Indication
14.11.9 Market Breakup by Distribution Channel
14.11.10 Market Breakup by End User
14.11.11 Key Players
14.11.12 Market Forecast (2024-2032)
14.12 Oman
14.12.1 Overview
14.12.2 Historical and Current Market Trends (2018-2023)
14.12.3 Market Breakup by Product Type
14.12.4 Market Breakup by Treatment Type
14.12.5 Market Breakup by Technology
14.12.6 Market Breakup by Route of Administration
14.12.7 Market Breakup by Patient Type
14.12.8 Market Breakup by Indication
14.12.9 Market Breakup by Distribution Channel
14.12.10 Market Breakup by End User
14.12.11 Key Players
14.12.12 Market Forecast (2024-2032)
14.13 Others
14.13.1 Historical and Current Market Trends (2018-2023)
14.13.2 Market Forecast (2024-2032)
15 MENA Vaccine Market – Competitive Landscape
15.1 Overview
15.2 Market Structure
15.3 Market Player Positioning
15.4 Top Winning Strategies
15.5 Competitive Dashboard
15.6 Company Evaluation Quadrant
16 Profiles of Key Players
16.1 Company A
16.1.1 Business Overview
16.1.2 Product Portfolio
16.1.3 Business Strategies
16.1.4 SWOT Analysis
16.1.5 Major News and Events
16.2 Company B
16.2.1 Business Overview
16.2.2 Product Portfolio
16.2.3 Business Strategies
16.2.4 SWOT Analysis
16.2.5 Major News and Events
16.3 Company C
16.3.1 Business Overview
16.3.2 Product Portfolio
16.3.3 Business Strategies
16.3.4 SWOT Analysis
16.3.5 Major News and Events
16.4 Company D
16.4.1 Business Overview
16.4.2 Product Portfolio
16.4.3 Business Strategies
16.4.4 SWOT Analysis
16.4.5 Major News and Events
16.5 Company E
16.5.1 Business Overview
16.5.2 Product Portfolio
16.5.3 Business Strategies
16.5.4 SWOT Analysis
16.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
17 MENA Vaccine Market - Industry Analysis
17.1 Drivers, Restraints, and Opportunities
17.1.1 Overview
17.1.2 Drivers
17.1.3 Restraints
17.1.4 Opportunities
17.2 Porters Five Forces Analysis
17.2.1 Overview
17.2.2 Bargaining Power of Buyers
17.2.3 Bargaining Power of Suppliers
17.2.4 Degree of Competition
17.2.5 Threat of New Entrants
17.2.6 Threat of Substitutes
17.3 Value Chain Analysis
18 Appendix
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More